ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Local recurrence rates following Mohs micrographic surgery compared with standard excision

Local recurrence rates following Mohs micrographic surgery compared with standard excision
Skin cancer Mohs micrographic surgery (MMS) Wide excision Follow-up period
Basal cell carcinoma[1-3]

1.4 to 4.4%

2.4 to 6.7%*

4.1 to 12.2%

13.5%*

 5 to 10 years
Squamous cell carcinoma[4,5]

1.2 to 2.6%

5.9%¶Δ

 5.7 to 8.1% (literature review rate)[6] 3.9 years (mean)
Dermatofibrosarcoma protuberans[7,8] 0 to 6.6%◊ 13.2% 4.8 to 5.4 years
Atypical fibroxanthoma[9,10] 0 8.7 to 12§% 4.5 to 8.7 years (median)
Extramammary Paget disease[11,12] 8¥ to 18.2% 22¥ to 36.4% 62.7 months (mean)
Sebaceous carcinoma[13,14] 11.1 to 12‡% 30% 37 months (mean)
Microcystic adnexal carcinoma[15,16] 0† to 5% 50% 5 years; only 13 cases
* Recurrent facial tumors.
¶ 5 years.
Δ Recurrent tumor.
◊ Based on a literature review.
§ 73.6 m.
¥ 24 m for MMS and 65 m for excision.
‡ 3.1 years (literature review rate).
† Mean.
References:
  1. Smeets NW, Krekels GA, Ostertag JU, et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: Randomised controlled trial. Lancet 2004; 364:1766.
  2. Leibovitch I, Huilgol SC, Selva D, et al. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol 2005; 53:452.
  3. Van Loo E, Mosterd K, Krekels GA, et al. Surgical excision versus Mohs micrographic surgery for basal cell carcinoma of the face: A randomized clinical trial with 10 year follow-up. Eur J Cancer 2014; 50:3011.
  4. Leibovitch I, Huilgol SC, Selva D, et al. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol 2005; 53:253.
  5. Pugliano-Mauro M, Goldman G. Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2010; 36:1544.
  6. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 26:976.
  7. Snow SN, Gordon EM, Larson PO, et al. Dermatofibrosarcoma protuberans: A report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature. Cancer 2004; 101:28.
  8. Paradisi A, Abeni D, Rusciani A, et al. Dermatofibrosarcoma protuberans: Wide local excision vs. Mohs micrographic surgery. Cancer Treat Rev 2008; 34:728.
  9. Ang GC, Roenigk RK, Otley CC, et al. More than 2 decades of treating atypical fibroxanthoma at mayo clinic: What have we learned from 91 patients? Dermatol Surg 2009; 35:765.
  10. Davis JL, Randle HW, Zalla MJ, et al. A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma. Dermatol Surg 1997; 23:105.
  11. Lee KY, Roh MR, Chung WG, Chung KY. Comparison of Mohs micrographic surgery and wide excision for extramammary Paget's Disease: Korean experience. Dermatol Surg 2009; 35:34.
  12. O'Connor WJ, Lim KK, Zalla MJ, et al. Comparison of mohs micrographic surgery and wide excision for extramammary Paget's disease. Dermatol Surg 2003; 29:723.
  13. Snow SN, Larson PO, Lucarelli MJ, et al. Sebaceous carcinoma of the eyelids treated by mohs micrographic surgery: Report of nine cases with review of the literature. Dermatol Surg 2002; 28:623.
  14. Spencer JM, Nossa R, Tse DT, Sequeira M. Sebaceous carcinoma of the eyelid treated with Mohs micrographic surgery. J Am Acad Dermatol 2001; 44:1004.
  15. Leibovitch I, Huilgol SC, Selva D, et al. Microcystic adnexal carcinoma: Treatment with Mohs micrographic surgery. J Am Acad Dermatol 2005; 52:295.
  16. Snow S, Madjar DD, Hardy S, et al. Microcystic adnexal carcinoma: Report of 13 cases and review of the literature. Dermatol Surg 2001; 27:401.
Graphic 65604 Version 3.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟